Native Cardio, founded in 2018 and headquartered in Naples, Florida, is a late-stage medical device development company focused on addressing postoperative atrial fibrillation. Their core mission is to restore quality of life for patients by identifying and addressing unmet needs in the healthcare environment. The company designs and develops innovative cardiovascular devices using the latest technology to meet these needs.
Notable affiliated individuals and investors include leading experts in cardiology and medical device innovation, though specific names are not provided. Key achievements involve the development of cutting-edge solutions for postoperative atrial fibrillation, significantly impacting patient outcomes. Native Cardio’s innovations have positioned it as a crucial player in the cardiovascular device market, contributing to advancements in patient care and medical technology.
